← Eichor
Study identifier: NCT03569826 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Canadian Network for Autoimmune Liver Disease

Condition: Primary Bilary Cirrhosis (PBC) · Autoimmune Hepatitis · Overlap Syndrome  ·  Sponsor: University Health Network, Toronto

PhaseN/A
Planned participants2500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

CaNAL is a longitudinal observational cohort study of patients diagnosed with Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH), or overlap syndrome. This study creates a nationwide registry and network focusing on high quality long-term follow-up of individual patient data from major Canadian centers. Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) are rare and slowly progressive liver diseases associated with development of cirrhosis, liver cancer (HCC) and liver failure requiring liver transplantation or leading to premature death. The rarity and slowly progressive nature of these autoimmune liver diseases make them difficult to study and only a large scale approach combining patient data from multiple centers across Canada will allow new insights. The primary aim of the Canadian Network for Autoimmune Liver Disease is to build a Canadian registry of patients with PBC, AIH, and overlap syndrome. We capture patient characteristics, laboratory assessments and natural history, patient-reported outcomes including quality of life measures and environmental exposures, response to treatment, and pre- and post-transplant outcomes. We will then identify risk factors associated with critical outcomes for the patient, including response to treatment, progression to transplant, risk of liver cancer, and recurrent disease after transplant. We can identify biomarkers (biochemical indicators of progression of disease) to help diagnose autoimmune liver diseas…

This description comes directly from the study's public registry record.

Talk to the study team

Surain Roberts, AB  ·  613 291 5039  ·  surain.roberts@uhn.ca

Kattleya Tirona, BA, CCRP  ·  416 340 4800  ·  kattleya.tirona@uhn.ca

Always discuss trial participation with your own doctor first.

Locations (15)

Foothills Medical CentreCalgary, Alberta, CanadaNot Yet Recruiting
University of Alberta HospitalEdmonton, Alberta, CanadaRecruiting
Vancouver General HospitalVancouver, British Columbia, CanadaNot Yet Recruiting
St. Paul's HospitalVancouver, British Columbia, CanadaNot Yet Recruiting
Health Sciences CentreWinnipeg, Manitoba, CanadaNot Yet Recruiting
Queen Elizabeth II Health Sciences CentreHalifax, Nova Scotia, CanadaActive Not Recruiting
McMaster University Medical CentreHamilton, Ontario, CanadaNot Yet Recruiting
Kingston Health Sciences Centre (HDH Site)Kingston, Ontario, CanadaActive Not Recruiting
London Health Sciences Centre - University HospitalLondon, Ontario, CanadaRecruiting
The Ottawa HospitalOttawa, Ontario, CanadaRecruiting
Toronto General HospitalToronto, Ontario, CanadaRecruiting
Centre hospitalier de l'Université de MontréalMontreal, Quebec, CanadaRecruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03569826